Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

SELL
$108.61 - $118.38 $4,561 - $4,971
-42 Reduced 0.04%
108,067 $12.5 Million
Q1 2023

Apr 13, 2023

BUY
$102.94 - $114.86 $444,494 - $495,965
4,318 Added 4.16%
108,109 $11.5 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $36,112 - $46,301
-413 Reduced 0.4%
103,791 $11.5 Million
Q4 2022

Jan 10, 2023

BUY
$87.44 - $112.11 $301,230 - $386,218
3,445 Added 3.42%
104,204 $11.6 Million
Q3 2022

Oct 11, 2022

BUY
$84.53 - $94.96 $114,115 - $128,195
1,350 Added 1.36%
100,759 $8.68 Million
Q2 2022

Jul 08, 2022

BUY
$83.49 - $94.64 $751,660 - $852,043
9,003 Added 9.96%
99,409 $9.06 Million
Q1 2022

Apr 12, 2022

BUY
$73.51 - $82.4 $6.65 Million - $7.45 Million
90,406 New
90,406 $7.42 Million
Q4 2020

Jan 13, 2021

SELL
$71.77 - $79.65 $14.5 Million - $16 Million
-201,400 Closed
0 $0
Q3 2020

Oct 08, 2020

BUY
$73.18 - $82.95 $7.57 Million - $8.58 Million
103,399 Added 105.51%
201,400 $16.7 Million
Q2 2020

Jul 17, 2020

SELL
$70.42 - $80.13 $631,244 - $718,285
-8,964 Reduced 8.38%
98,001 $7.58 Million
Q1 2020

Apr 09, 2020

SELL
$63.36 - $87.82 $98,208 - $136,121
-1,550 Reduced 1.43%
106,965 $8.23 Million
Q4 2019

Jan 22, 2020

BUY
$77.58 - $87.54 $73,856 - $83,338
952 Added 0.89%
108,515 $9.87 Million
Q3 2019

Oct 17, 2019

SELL
$76.08 - $82.93 $444,155 - $484,145
-5,838 Reduced 5.15%
107,563 $9.06 Million
Q2 2019

Jul 10, 2019

SELL
$69.84 - $81.59 $635,055 - $741,897
-9,093 Reduced 7.42%
113,401 $9.51 Million
Q1 2019

Apr 12, 2019

SELL
$69.58 - $79.36 $512,317 - $584,327
-7,363 Reduced 5.67%
122,494 $10.2 Million
Q4 2018

Jan 15, 2019

BUY
$65.24 - $75.71 $8.47 Million - $9.83 Million
129,857 New
129,857 $9.92 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $219B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Churchill Management Corp Portfolio

Follow Churchill Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Churchill Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Churchill Management Corp with notifications on news.